Legal & General Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.46M | Buy |
|
|||||
|
2025
Q2 | $1.81M | Buy |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $1.61M | Buy |
|
|||||
|
2024
Q3 | $1.76M | Sell |
|
|||||
|
2024
Q2 | $1.33M | Buy |
|
|||||
|
2024
Q1 | $1.71M | Buy |
|
|||||
|
2023
Q4 | $977K | Buy |
|
|||||
|
2023
Q3 | $431K | Sell |
|
|||||
|
2023
Q2 | $719K | Sell |
|
|||||
|
2023
Q1 | $1.04M | Buy |
|
|||||
|
2022
Q4 | $828K | Buy |
|
|||||
|
2022
Q3 | $713K | Buy |
|
|||||
|
2022
Q2 | $565K | Buy |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $870K | Buy |
|
|||||
|
2021
Q3 | $787K | Buy |
|
|||||
|
2021
Q2 | $324K | Buy |
|
|||||
|
2021
Q1 | $67K | Sell |
|
|||||
|
2020
Q4 | $109K | Buy |
|